Ballew Advisors’s BIMI International Medical Inc. Common Stock BIMI Stock Holding History

Ballew Advisors’s Portfolio BIMI Stock Details BIMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-300	Closed	-$6K	–	131
2021 Q4	$6K	Buy	+300	New	+$10.7K	﹤0.01%	118

Other funds holding BIMI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Financial Perspectives Minneapolis, Minnesota $411M AUM 26.27% 1-Year Est. Return

Ballew Advisors's BIMI Position: Q1 2022 in Review

Ballew Advisors sold out of BIMI International Medical Inc. Common Stock (BIMI) in Q1 2022, closing a stake of 300 shares — an estimated $6K sold.

Ballew Advisors first reported a position in BIMI in Q4 2021 and held it in 1 quarter. The position peaked at $6K in Q4 2021. 9 funds tracked by Wall St. Rank hold BIMI as of Q1 2022.

Ballew Advisors reported no remaining BIMI International Medical Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Ballew Advisors sold 300 BIMI International Medical Inc. Common Stock shares in Q1 2022, an estimated $6K.
Ballew Advisors first reported a position in BIMI International Medical Inc. Common Stock in Q4 2021 and held it in 1 quarter.
Ballew Advisors's BIMI International Medical Inc. Common Stock position peaked at $6K in Q4 2021.
9 funds tracked by Wall St. Rank held BIMI International Medical Inc. Common Stock as of Q1 2022.

Based on Ballew Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.